Smelik et al. investigate the effectiveness of using multi-omics biomarkers in blood for cancer screening. The results indicate that while these biomarkers show promise for diagnosing individual cancers in close proximity to the blood stream, they do not surpass clinical variables for diagnosing multiple cancers.
- Martin Smelik
- Yelin Zhao
- Mikael Benson